Hepatitis B shot hailed as potential cure
Boston AP reports scientists announce a synthetic interferon treatment may relieve and cure chronic hepatitis B in some patients. In a New England Journal study, about half of chronically infected individuals avoided liver damage, with around 10 percent cured, while 60 percent saw no benefit. Hepatitis B remains a leading cause of liver disease worldwide.